Skip to main content

GOLDMAN SACHS GROUP INC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 886982 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,237,727
+$3,816,245 QoQ
Shares Held
191,364
+9.4% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. KNSA ranks #27 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,237,727 191,364
2026-03-31 $8,421,482 174,901
2025-12-31 $34,213,451 829,417
2025-09-30 $21,220,982 546,510
2025-06-30 $10,616,093 383,668
2025-03-31 $3,472,044 156,328
2024-12-31 $4,177,278 211,187
2024-09-30 $12,704,241 508,373